Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Vs. Host Disease (aGVHD) in Patients with Hematological Malignancies Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT)

Yvonne A Efebera, MD, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, MS, Rhonda Kitzler, BS, Kevin Coombes, PhD, Carrie Hennelly, MA, Katie Cortright, BS, Leslie A. Andritsos, MD, Samantha M. Jaglowski, MD MPH, Sumithira Vasu, MBBS, William Blum, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Craig C Hofmeister, MD MPH, Don M Benson, MD PhD, Gerard Lozanski, MD, Steven M. Devine, MD

Blood (2014) 124 (21): 3929.

https://doi.org/10.1182/blood.V124.21.3929.3929

Published: 2014

Journal Articles

A Phase I/II Trial of the Histone Deacetylase (HDAC) Inhibitor, Panobinostat, in Combination with Lenalidomide in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (HL)

Beth Christian, MD, Lai Wei, Jennifer Sexton, Samantha M. Jaglowski, MD MPH, Steven M. Devine, MD, Todd A. Fehniger, MD PhD, Nina Wagner-Johnston, Nancy L. Bartlett, MD, Kristie A. Blum, MD

Blood (2014) 124 (21): 3099.

https://doi.org/10.1182/blood.V124.21.3099.3099

Published: 2014

Journal Articles

A Phase II Study of MLN8237 (Alisertib) Alone and in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Beth Christian, MD, Joseph M Flynn, DO, MPH, Samantha M. Jaglowski, MD MPH, Kristie A. Blum, MD

Blood (2014) 124 (21): 3082.

https://doi.org/10.1182/blood.V124.21.3082.3082

Published: 2014

Journal Articles

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

Yvonne A Efebera, MD, Susan Geyer, PhD, Anissa Bingman, M.S., Rhonda Kitzler, BS, Patrick Elder, MS, Leslie A. Andritsos, MD, Samantha M. Jaglowski, MD MPH, Sumithira Vasu, MBBS, William Blum, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Kevin Coombes, PhD, Craig C Hofmeister, MD MPH, Don Benson, MD PhD, Steven M. Devine, MD, Gerard Lozanski, MD

Blood (2014) 124 (21): 1166.

https://doi.org/10.1182/blood.V124.21.1166.1166

Published: 2014

Journal Articles

A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies

Bradley M. Haverkos, MD MPH, Katie Cortright, BS, Leslie A. Andritsos, MD, William Blum, MD, Rebecca B. Klisovic, MD, Sumithira Vasu, MBBS, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Steven M. Devine, MD, Samantha M. Jaglowski, MD MPH

Blood (2014) 124 (21): 1168.

https://doi.org/10.1182/blood.V124.21.1168.1168

Published: 2014

Journal Articles

Allograft T-Cell, T-Regs, NK-Cell and B-Cell Content Influence Distinct Clinical Outcomes Following G-CSF Mobilized Hematopoietic Stem Cell Transplantation

Sumithira Vasu, MBBS, Anissa Bingman, M.S., Susan Geyer, PhD, Patrick Elder, Rhonda Kitzler, BS, Hillary Bradbury, Lynn Odonnell, William Blum, MD, Samantha M. Jaglowski, MD MPH, Leslie A. Andritsos, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, MD, Craig C. Hofmeister, MD, Don M. Benson, MD PhD, Natarajan Muthusamy, DVM, PhD, Gerard Lozanski, MD, Steven M. Devine, MD

Blood (2014) 124 (21): 2494.

https://doi.org/10.1182/blood.V124.21.2494.2494

Published: 2014

Journal Articles

Changing The Treatment Paradigm For Previously Treated Chronic Lymphocytic Leukemia Patients With Del(17p) Karyotype

Deborah M Stephens, DO, Amy Stark, MAS, Jeffrey A. Jones, MD, MPH, Jennifer A. Woyach, MD, Kami Maddocks, Samantha M. Jaglowski, MD, MPH, Leslie A. Andritsos, MD, Joseph M. M. Flynn, DO, MPH, Michael R. Grever, MD, Gerard Lozanski, MD, Amy J. Johnson, PhD, Natarajan Muthusamy, DVM, Ph.D, Nyla A. Heerema, PhD, John C. Byrd, MD

Blood (2013) 122 (21): 2872.

https://doi.org/10.1182/blood.V122.21.2872.2872

Published: 2013

Journal Articles

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

Areej El-Jawahri, MD, Joseph Pidala, MD, MS, Xiaoyu Chai, MS, William A. Wood, MD, MPH, Nandita Khera, MD, MPH, Mukta Arora, MD, MS, Samantha M. Jaglowski, MD, MPH, Stephanie J. Lee, MD, MPH, Yi-Bin Chen, MD

Blood (2013) 122 (21): 725.

https://doi.org/10.1182/blood.V122.21.725.725

Published: 2013

Journal Articles

Externally Validated Predictive Clinical Model For Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

Deborah M Stephens, DO, Amy Stark, MAS, William G. Wierda, MD, PhD, Jeffrey A. Jones, MD, MPH, Jennifer A. Woyach, MD, Kami Maddocks, Samantha M. Jaglowski, MD, MPH, Leslie A Andritsos, MD, Joseph M. M. Flynn, DO, MPH, Michael R. Grever, MD, Gerard Lozanski, MD, Constantine S Tam, MBBS, FRACP, FRCPA, MD, Susan O'Brien, MD, Michael J. Keating, MD, Natarajan Muthusamy, DVM, Ph.D, Lynne V. Abruzzo, MD, PhD, Nyla A. Heerema, PhD, John C. Byrd, MD

Blood (2013) 122 (21): 4128.

https://doi.org/10.1182/blood.V122.21.4128.4128

Published: 2013

Journal Articles

A Phase I Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Combination with Rituximab (R) and Bendamustine in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)

Kristie A. Blum, MD, Beth Christian, MD, Joseph M. Flynn, DO, MPH, Samantha M. Jaglowski, MD, MPH, Jeffrey Alan Jones, MD, MPH, Kami Maddocks, MD, John C. Byrd, MD

Blood (2012) 120 (21): 1643.

https://doi.org/10.1182/blood.V120.21.1643.1643

Published: 2012

Journal Articles

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Jianhua Yu, PhD, Shun He, Lai-Chu Wu, PhD, Hsiaoyin Mao, Sumithira Vasu, MBBS, Samantha M. Jaglowski, MD, MPH, Yong Peng, Christopher Alvarez-Breckenridge, Shunzong Yuan, Ph.D., M.D., Min Wei, Jianying Zhang, Tiffany L Hughes, Kalpana Ghoshal, Steven M. Devine, MD, Michael A. Caligiuri, M.D.

Blood (2012) 120 (21): 2160.

https://doi.org/10.1182/blood.V120.21.2160.2160

Published: 2012

Journal Articles

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Samantha M. Jaglowski, MD, MPH, Sumithira Vasu, MBBS, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, MS, Jianhua Yu, PhD, William Blum, MD, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD, Don M. Benson, Jr., MD, PhD, Natarajan Muthusamy, DVM, Ph.D, Steven M. Devine, MD, Leslie A Andritsos, MD, Gerard Lozanski, MD

Blood (2012) 120 (21): 1949.

https://doi.org/10.1182/blood.V120.21.1949.1949

Published: 2012

Journal Articles

Ibrutinib Is an Irreversible Molecular Inhibitor of Interleukin-2 Inducible Kinase: Expanding Therapeutic Potential and Modulating a Th1 Selective Pressure in CD4 T-Cells

Blood (2012) 120 (21): 775.

https://doi.org/10.1182/blood.V120.21.775.775

Published: 2012

Journal Articles

Immunomodulation of Both Donors and Recipients with Atorvastatin As a Strategy for the Prevention of Acute Graft-Versus-Host Disease (aGVHD): Results of Two Parallel Prospective Trials in Recipients of Matched Sibling Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Blood (2012) 120 (21): 1942.

https://doi.org/10.1182/blood.V120.21.1942.1942

Published: 2012

Journal Articles

Differential Distribution of Activated Innate and Adaptive Immune Subsets in G-CSF Mobilized Hematopoietic Stem Cell Allografts May Influence Incidence of Acute (aGVHD) and Chronic Graft-Versus-Host Disease (cGVHD)

Sumithira Vasu, MBBS, Samantha M. Jaglowski, MD, MPH, Susan Geyer, PhD, Anissa Bingman, M.S., Patrick Elder, M.S., Jianhua Yu, PhD, Leslie A Andritsos, MD, William Blum, MD, Rebecca B Klisovic, MD, Sam Penza, MD, Yvonne A Efebera, M.D., Craig C. Hofmeister, MD, Don M. Benson, Jr., MD, PhD, Natarajan Muthusamy, DVM, Ph.D, Steven M. Devine, MD, Gerard Lozanski, M.D.

Blood (2012) 120 (21): 4192.

https://doi.org/10.1182/blood.V120.21.4192.4192

Published: 2012

Journal Articles

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

Samantha M. Jaglowski, MD, MPH, Craig C. Hofmeister, MD, Patrick Elder, MS, Sam Penza, MD, Yvonne A Efebera, M.D., Don M. Benson, Jr., MD, PhD, Steven M. Devine, MD, Leslie A Andritsos, MD

Blood (2012) 120 (21): 4286.

https://doi.org/10.1182/blood.V120.21.4286.4286

Published: 2012

NARROW

Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Vs. Host Disease (aGVHD) in Patients with Hematological Malignancies Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo HSCT)

A Phase I/II Trial of the Histone Deacetylase (HDAC) Inhibitor, Panobinostat, in Combination with Lenalidomide in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (HL)

A Phase II Study of MLN8237 (Alisertib) Alone and in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NHL)

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies

Allograft T-Cell, T-Regs, NK-Cell and B-Cell Content Influence Distinct Clinical Outcomes Following G-CSF Mobilized Hematopoietic Stem Cell Transplantation

Changing The Treatment Paradigm For Previously Treated Chronic Lymphocytic Leukemia Patients With Del(17p) Karyotype

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

Externally Validated Predictive Clinical Model For Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

A Phase I Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Combination with Rituximab (R) and Bendamustine in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL)

Micrornas Promote Activation and Maturation of Natural Killer Cells Through Toll-Like Receptor Signaling.

Immune Reconstitution At Days 30 and 100 Following Allogeneic Stem Cell Transplant and Association with Subsequent Development of Chronic Graft-Versus-Host Disease

Ibrutinib Is an Irreversible Molecular Inhibitor of Interleukin-2 Inducible Kinase: Expanding Therapeutic Potential and Modulating a Th1 Selective Pressure in CD4 T-Cells

Immunomodulation of Both Donors and Recipients with Atorvastatin As a Strategy for the Prevention of Acute Graft-Versus-Host Disease (aGVHD): Results of Two Parallel Prospective Trials in Recipients of Matched Sibling Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Differential Distribution of Activated Innate and Adaptive Immune Subsets in G-CSF Mobilized Hematopoietic Stem Cell Allografts May Influence Incidence of Acute (aGVHD) and Chronic Graft-Versus-Host Disease (cGVHD)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only